PATENT CLAIM ANALYSIS

Application Number: 15875678
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "183000"]

Abstract:
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Claim (Index 106):
The compound according to  claim 105 , wherein X is \u2014CH 2 \u2014, and one or more hydrogens may be independently replaced with deuterium or halogen.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.26667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15486256', '15492838', '15424616', '15531204', '15459886']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7867485491214624
- 35 USC 102 Novelty (BERT): 0.6220197956421811
- Combined Prediction Score: 0.7702756737735343
- Mean Citation Score: 490.520882
- Max Citation Score: 588.06445
- Similarity Product: 497.5820655180991

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test